Eargo Link vs Otofonix Encore

The Eargo Link is a mid-priced OTC hearing aid released in 2024, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $799, it ranks #15 of 65 OTC hearing aids tested, placing it in the top 22% of the category. In our testing, the Eargo Link demonstrates notable strengths in music streaming, scoring 4.4/5—a strong result that sits 2.48 points above the category average. This makes it a standout choice for users who prioritize audio quality when streaming from their phone. Speech performance is solid, with speech in quiet measuring 3.2/5 (0.42 points above average) and speech in noise at 2.0/5 (0.54 points above average, though mixed in absolute terms). Feedback handling is excellent at 4.7/5. The main limitation is own-voice comfort, which scores 1.3/5—a low result that falls 1.21 points below the category average. Users sensitive to the sound of their own voice may find this challenging, particularly with the closed dome configuration used in the tuned fit. The Eargo Link supports both iPhone and Android streaming with hands-free capability and uses rechargeable batteries. It's best suited for those who value exceptional music streaming quality and solid speech clarity, and who can tolerate some own-voice occlusion. Competitors in this price range include higher-scoring options like the Yeasound RIC800 and Sony CRE-E10, though the Eargo Link's streaming performance remains a differentiator.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.